Marc Scheineson spoke at this summit, which provided an update on the industry's progress towards full disclosure and addressed the impact trial registries have had, if any, on public perception, global standardization initiatives such as the FDA's clinicaltrials.gov, WHO"s ICTRP, AMIA's GTB and EMEA's EudraCT, and the ethical, regulatory and legal responsibilities of the industry. Marc's topic was "Is it the State's Responsibility to Fill the Gaps Left by FDAMA 113?"
January 22-23, 2007
Mandarin Oriental Hotel / Washington, D.C.